Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Stroke in 19 Major Markets
Stroke is a serious cerebrovascular event constituting one of the most common causes of long-term disability and death, and a major burden to public health worldwide. According to WHO, stroke is “a clinical syndrome consisting of rapidly developing clinical signs of focal (or global in case of coma) disturbance of cerebral function lasting more than 24 hours or leading to death with no apparent cause other than a vascular origin.”
This report provides the current incident population for stroke across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current incidence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several features of stroke patients, as well as the main types and subtypes of the disease have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of stroke include:
• Cardiovascular conditions (mainly cardiac arrhythmias and myocardial infarction)
• Venous thromboembolism (DVT, pulmonary embolism)
• Hypertension
• Diabetes mellitus
• Pneumonia
• Urinary tract infections
• Fractures (due to falls caused by physical disability)
• Pain
• Depression
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Ability to quantify patient populations in global stroke market to target the development of future products, pricing strategies and launch plans.
• Further insight into the incidence of the subdivided types of stroke and identification of patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Better understanding of the impact of specific co-morbid conditions on the incident population of stroke patients.
• Identification of stroke patient sub-populations that require treatment.
• Better understanding of the specific markets that have the largest number of stroke patients.
CONTENTS
• LIST OF TABLES AND FIGURES
• INTRODUCTION
• CAUSE OF THE DISEASE
• RISK FACTORS & PREVENTION
• DIAGNOSIS OF THE DISEASE
• VARIATION BY GEOGRAPHY/ETHNICITY
• DISEASE PROGNOSIS & CLINICAL COURSE
• KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE
• METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
• TOP-LINE INCIDENCE FOR STROKE
• FEATURES OF STROKE PATIENTS
• INFARCTION STROKE
• HAEMORRHAGIC STROKE
• ABBREVIATIONS USED IN THE REPORT
• OTHER BLACK SWAN SERVICES & SOLUTIONS
• REPORTS & PUBLICATIONS
• ONLINE EPIDEMIOLOGY DATABASES
• ONLINE PHARMACEUTICAL PRICING DATABASE
• REFERENCES
• APPENDIX
LIST OF TABLES AND FIGURES
• Table 1. The National Institutes of Health Stroke Scale (NIHSS)
• Table 2. Stroke severity grades as determined by the NIHSS score
• Table 3. Incidence of stroke, total (000s)
• Table 4. Incidence of stroke, males (000s)
• Table 5. Incidence of stroke, females (000s)
• Table 6. Patients with stroke by type of disease, total (000s)
• Table 7. Stroke patients with recurrent stroke event, total (000s)
• Table 8. Patients with infarction stroke by type of infarction, total (000s)
• Table 9. Patients with embolic stroke by GCS score, total (000s)
• Table 10. Patients with embolic stroke by type of sensory deficits, total (000s)
• Table 11. Patients with embolic stroke by type of language disturbance, total (000s)
• Table 12. Patients with atherosclerotic stroke by GCS score, total (000s)
• Table 13. Patients with atherosclerotic stroke by type of sensory deficits, total (000s)
• Table 14. Patients with atherosclerotic stroke by type of language disturbance, total (000s)
• Table 15. Patients with lacunar stroke by GCS score, total (000s)
• Table 16. Patients with lacunar stroke by type of sensory deficits, total (000s)
• Table 17. Patients with lacunar stroke by type of language disturbance, total (000s)
• Table 18. Patients with stroke of unknown cause by GCS score, total (000s)
• Table 19. Patients with stroke of unknown cause by type of sensory deficits, total (000s)
• Table 20. Patients with stroke of unknown cause by type of language disturbance, total (000s)
• Table 21. Patients with haemorrhagic stroke by type of haemorrhage, total (000s)
• Table 22. Patients with haemorrhagic intracerebral stroke by GCS score, total (000s)
• Table 23. Patients with haemorrhagic intracerebral stroke by type of sensory deficits, total (000s)
• Table 24. Patients with haemorrhagic intracerebral stroke by type of language disturbance, total (000s)
• Table 25. Patients with haemorrhagic subarachnoid stroke by GCS score, total (000s)
• Table 26. Patients with haemorrhagic subarachnoid stroke by type of sensory deficits, total (000s)
• Table 27. Patients with haemorrhagic intracerebral stroke by type of language disturbance, total (000s)
• Table 28. Abbreviations and acronyms used in the report
• Table 29. USA incidence of stroke by 5-yr age cohort, males (000s)
• Table 30. USA incidence of stroke by 5-yr age cohort, females (000s)
• Table 31. Canada incidence of stroke by 5-yr age cohort, males (000s)
• Table 32. Canada incidence of stroke by 5-yr age cohort, females (000s)
• Table 33. France incidence of stroke by 5-yr age cohort, males (000s)
• Table 34. France incidence of stroke by 5-yr age cohort, females (000s)
• Table 35. Germany incidence of stroke by 5-yr age cohort, males (000s)
• Table 36. Germany incidence of stroke by 5-yr age cohort, females (000s)
• Table 37. Italy incidence of stroke by 5-yr age cohort, males (000s)
• Table 38. Italy incidence of stroke by 5-yr age cohort, females (000s)
• Table 39. Spain incidence of stroke by 5-yr age cohort, males (000s)
• Table 40. Spain incidence of stroke by 5-yr age cohort, females (000s)
• Table 41. UK incidence of stroke by 5-yr age cohort, males (000s)
• Table 42. UK incidence of stroke by 5-yr age cohort, females (000s)
• Table 43. Poland incidence of stroke by 5-yr age cohort, males (000s)
• Table 44. Poland incidence of stroke by 5-yr age cohort, females (000s)
• Table 45. Netherlands incidence of stroke by 5-yr age cohort, males (000s)
• Table 46. Netherlands incidence of stroke by 5-yr age cohort, females (000s)
• Table 47. Russia incidence of stroke by 5-yr age cohort, males (000s)
• Table 48. Russia incidence of stroke by 5-yr age cohort, females (000s)
• Table 49. Turkey incidence of stroke by 5-yr age cohort, males (000s)
• Table 50. Turkey incidence of stroke by 5-yr age cohort, females (000s)
• Table 51. Japan incidence of stroke by 5-yr age cohort, males (000s)
• Table 52. Japan incidence of stroke by 5-yr age cohort, females (000s)
• Table 53. China incidence of stroke by 5-yr age cohort, males (000s)
• Table 54. China incidence of stroke by 5-yr age cohort, females (000s)
• Table 55. South Korea incidence of stroke by 5-yr age cohort, males (000s)
• Table 56. South Korea incidence of stroke by 5-yr age cohort, females (000s)
• Table 57. India incidence of stroke by 5-yr age cohort, males (000s)
• Table 58. India incidence of stroke by 5-yr age cohort, females (000s)
• Table 59. Australia incidence of stroke by 5-yr age cohort, males (000s)
• Table 60. Australia incidence of stroke by 5-yr age cohort, females (000s)
• Table 61. Brazil incidence of stroke by 5-yr age cohort, males (000s)
• Table 62. Brazil incidence of stroke by 5-yr age cohort, females (000s)
• Table 63. Mexico incidence of stroke by 5-yr age cohort, males (000s)
• Table 64. Mexico incidence of stroke by 5-yr age cohort, females (000s)
• Table 65. Argentina incidence of stroke by 5-yr age cohort, males (000s)
• Table 66. Argentina incidence of stroke by 5-yr age cohort, females (000s)
